Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cancellieri

Showing results (31-40 of 1,484) with videos related to

Pageof 149
Sort By:
Respiratory Medicine Case Reports|November 14, 2019
Granular cell tumor of the trachea as a rare cause of dyspnea in a young womanA Rizzo, E D Serban, A D Ricci, et al.
Minerva Medica|October 19, 2000
Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot studyP Lippe, R R Silva, L Giuliodori, et al.
Haematologica|July 16, 1999
Core needle biopsy is effective in the initial diagnosis of mediastinal lymphomaP L Zinzani, G Corneli, A Cancellieri, et al.
Gut|June 1, 1988
Intramural distribution of regulatory peptides in the sigmoid-recto-anal region of the human gutG L Ferri, T E Adrian, J M Allen, et al.
British Journal of Cancer|November 17, 2005
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patientsF Cappuzzo, L Toschi, I Domenichini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibF Cappuzzo, L Toschi, G Tallini, et al.
ESMO Open|August 30, 2025
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinibE Vita, A Scala, A Vitale, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 2, 2023
RIFM natural complex substance (NCS) fragrance ingredient safety assessment, Mandarin oil terpenes, CAS registry number 68953-04-8, RIFM ID 250-G2.30A M Api, D Belsito, D Botelho, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 14, 2024
Update to RIFM fragrance ingredient safety assessment, terpinyl acetate (isomer mixture), CAS Registry Number 8007-35-0A M Api, D Belsito, D Botelho, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 1, 2023
RIFM fragrance ingredient safety assessment, (1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide, CAS Registry Number 68489-09-8A M Api, D Belsito, D Botelho, et al.
Pageof 149

Showing results (31-40 of 1,484) with videos related to

Sort By:
Pageof 149
Respiratory Medicine Case Reports|November 14, 2019
Granular cell tumor of the trachea as a rare cause of dyspnea in a young womanA Rizzo, E D Serban, A D Ricci, et al.
Minerva Medica|October 19, 2000
Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot studyP Lippe, R R Silva, L Giuliodori, et al.
Haematologica|July 16, 1999
Core needle biopsy is effective in the initial diagnosis of mediastinal lymphomaP L Zinzani, G Corneli, A Cancellieri, et al.
Gut|June 1, 1988
Intramural distribution of regulatory peptides in the sigmoid-recto-anal region of the human gutG L Ferri, T E Adrian, J M Allen, et al.
British Journal of Cancer|November 17, 2005
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patientsF Cappuzzo, L Toschi, I Domenichini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibF Cappuzzo, L Toschi, G Tallini, et al.
ESMO Open|August 30, 2025
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinibE Vita, A Scala, A Vitale, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 2, 2023
RIFM natural complex substance (NCS) fragrance ingredient safety assessment, Mandarin oil terpenes, CAS registry number 68953-04-8, RIFM ID 250-G2.30A M Api, D Belsito, D Botelho, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 14, 2024
Update to RIFM fragrance ingredient safety assessment, terpinyl acetate (isomer mixture), CAS Registry Number 8007-35-0A M Api, D Belsito, D Botelho, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 1, 2023
RIFM fragrance ingredient safety assessment, (1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide, CAS Registry Number 68489-09-8A M Api, D Belsito, D Botelho, et al.
Pageof 149